Alterations in IRF1/IRF2 expression in acute myelogenous leukemia

H. D. Preisler, S. Perambakam, B. Li, W. T. Hsu, P. Venugopal, S. Creech, S. Sivaraman, N. Tanaka

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The interferon response genes 1 and 2 have been shown to be involved in the regulation of differentiation and proliferation of cells of the myeloid series, with the former functioning as an anti-oncogene and the latter as an oncogene. In the study described here, the levels of expression of these two genes and the ratio of their expression were compared in AML and normal marrow. The ratio of gene expression was significantly less in AML marrow cells as compared to normal marrow cells [med ratio = 1.33 vs. 2.97, P = 0.003]. While the expression ratio was unaffected by the presence or absence of either ras or fms mutations, p53 mutations were associated with higher IRF1:IRF2 expression ratios that wt p53 genes [med = 1.701 vs. 1.135, P = 0.014]. Given the functional characteristics and the competitive nature of these two genes, it is possible that leukemic transformation is associated with a fall in IRF1:IRF2 ratios. Finally, the administration of IL4 can result in the normalization of the IRF1:IRF2 ratio in the marrow cells of some patients with AML.

Original languageEnglish (US)
Pages (from-to)23-31
Number of pages9
JournalAmerican Journal of Hematology
Volume68
Issue number1
DOIs
StatePublished - Aug 23 2001
Externally publishedYes

Fingerprint

Acute Myeloid Leukemia
Bone Marrow
Gene Expression
Mutation
p53 Genes
Myeloid Cells
Tumor Suppressor Genes
Oncogenes
Interleukin-4
Interferons
Genes
Cell Differentiation
Cell Proliferation

Keywords

  • Acute leukemia
  • IRF1
  • IRF2

ASJC Scopus subject areas

  • Hematology

Cite this

Preisler, H. D., Perambakam, S., Li, B., Hsu, W. T., Venugopal, P., Creech, S., ... Tanaka, N. (2001). Alterations in IRF1/IRF2 expression in acute myelogenous leukemia. American Journal of Hematology, 68(1), 23-31. https://doi.org/10.1002/ajh.1144

Alterations in IRF1/IRF2 expression in acute myelogenous leukemia. / Preisler, H. D.; Perambakam, S.; Li, B.; Hsu, W. T.; Venugopal, P.; Creech, S.; Sivaraman, S.; Tanaka, N.

In: American Journal of Hematology, Vol. 68, No. 1, 23.08.2001, p. 23-31.

Research output: Contribution to journalArticle

Preisler, HD, Perambakam, S, Li, B, Hsu, WT, Venugopal, P, Creech, S, Sivaraman, S & Tanaka, N 2001, 'Alterations in IRF1/IRF2 expression in acute myelogenous leukemia', American Journal of Hematology, vol. 68, no. 1, pp. 23-31. https://doi.org/10.1002/ajh.1144
Preisler HD, Perambakam S, Li B, Hsu WT, Venugopal P, Creech S et al. Alterations in IRF1/IRF2 expression in acute myelogenous leukemia. American Journal of Hematology. 2001 Aug 23;68(1):23-31. https://doi.org/10.1002/ajh.1144
Preisler, H. D. ; Perambakam, S. ; Li, B. ; Hsu, W. T. ; Venugopal, P. ; Creech, S. ; Sivaraman, S. ; Tanaka, N. / Alterations in IRF1/IRF2 expression in acute myelogenous leukemia. In: American Journal of Hematology. 2001 ; Vol. 68, No. 1. pp. 23-31.
@article{5f94bd080c444d84a2bd51c34c002eed,
title = "Alterations in IRF1/IRF2 expression in acute myelogenous leukemia",
abstract = "The interferon response genes 1 and 2 have been shown to be involved in the regulation of differentiation and proliferation of cells of the myeloid series, with the former functioning as an anti-oncogene and the latter as an oncogene. In the study described here, the levels of expression of these two genes and the ratio of their expression were compared in AML and normal marrow. The ratio of gene expression was significantly less in AML marrow cells as compared to normal marrow cells [med ratio = 1.33 vs. 2.97, P = 0.003]. While the expression ratio was unaffected by the presence or absence of either ras or fms mutations, p53 mutations were associated with higher IRF1:IRF2 expression ratios that wt p53 genes [med = 1.701 vs. 1.135, P = 0.014]. Given the functional characteristics and the competitive nature of these two genes, it is possible that leukemic transformation is associated with a fall in IRF1:IRF2 ratios. Finally, the administration of IL4 can result in the normalization of the IRF1:IRF2 ratio in the marrow cells of some patients with AML.",
keywords = "Acute leukemia, IRF1, IRF2",
author = "Preisler, {H. D.} and S. Perambakam and B. Li and Hsu, {W. T.} and P. Venugopal and S. Creech and S. Sivaraman and N. Tanaka",
year = "2001",
month = "8",
day = "23",
doi = "10.1002/ajh.1144",
language = "English (US)",
volume = "68",
pages = "23--31",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Alterations in IRF1/IRF2 expression in acute myelogenous leukemia

AU - Preisler, H. D.

AU - Perambakam, S.

AU - Li, B.

AU - Hsu, W. T.

AU - Venugopal, P.

AU - Creech, S.

AU - Sivaraman, S.

AU - Tanaka, N.

PY - 2001/8/23

Y1 - 2001/8/23

N2 - The interferon response genes 1 and 2 have been shown to be involved in the regulation of differentiation and proliferation of cells of the myeloid series, with the former functioning as an anti-oncogene and the latter as an oncogene. In the study described here, the levels of expression of these two genes and the ratio of their expression were compared in AML and normal marrow. The ratio of gene expression was significantly less in AML marrow cells as compared to normal marrow cells [med ratio = 1.33 vs. 2.97, P = 0.003]. While the expression ratio was unaffected by the presence or absence of either ras or fms mutations, p53 mutations were associated with higher IRF1:IRF2 expression ratios that wt p53 genes [med = 1.701 vs. 1.135, P = 0.014]. Given the functional characteristics and the competitive nature of these two genes, it is possible that leukemic transformation is associated with a fall in IRF1:IRF2 ratios. Finally, the administration of IL4 can result in the normalization of the IRF1:IRF2 ratio in the marrow cells of some patients with AML.

AB - The interferon response genes 1 and 2 have been shown to be involved in the regulation of differentiation and proliferation of cells of the myeloid series, with the former functioning as an anti-oncogene and the latter as an oncogene. In the study described here, the levels of expression of these two genes and the ratio of their expression were compared in AML and normal marrow. The ratio of gene expression was significantly less in AML marrow cells as compared to normal marrow cells [med ratio = 1.33 vs. 2.97, P = 0.003]. While the expression ratio was unaffected by the presence or absence of either ras or fms mutations, p53 mutations were associated with higher IRF1:IRF2 expression ratios that wt p53 genes [med = 1.701 vs. 1.135, P = 0.014]. Given the functional characteristics and the competitive nature of these two genes, it is possible that leukemic transformation is associated with a fall in IRF1:IRF2 ratios. Finally, the administration of IL4 can result in the normalization of the IRF1:IRF2 ratio in the marrow cells of some patients with AML.

KW - Acute leukemia

KW - IRF1

KW - IRF2

UR - http://www.scopus.com/inward/record.url?scp=0034898502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034898502&partnerID=8YFLogxK

U2 - 10.1002/ajh.1144

DO - 10.1002/ajh.1144

M3 - Article

C2 - 11559933

AN - SCOPUS:0034898502

VL - 68

SP - 23

EP - 31

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 1

ER -